Supportive Care for Patients with Leukemia: A Historical Perspective

3.
Murphy S, Gardner FH. Room temperature storage of platelets. Transfusion. 1976;16:2–3.PubMedCrossRef
4.
Hogge DE, Thompson BW, Schiffer CA. Platelet storage for 7 days in second-generation blood bags. Transfusion. 1986;26:131–5.PubMedCrossRef
5.
Ness P, Braine H, King K, et al. Single-donor platelets reduce the risk of septic platelet transfusion reactions. Transfusion. 2001;41:857–61.PubMedCrossRef
6.
Schiffer CA, Lee EJ, Ness PM, Reilly J. Clinical evaluation of platelet concentrates stored for one to five days. Blood. 1986;67:1591–4.PubMed
7.
Dutcher JP, Schiffer CA, Aisner J, Wiernik PH. Alloimmunization following platelet transfusion: the absence of a dose-response relationship. Blood. 1981;57:395–8.PubMed
8.
Duquesnoy RJ, Filip DJ, Rodey GE, Rimm AA, Aster RH. Successful transfusion of platelets “mismatched” for HLA antigens to alloimmunized thrombocytopenic patients. Am J Hematol. 1977;2:219–26.PubMedCrossRef
9.
Duquesnoy RJ, Testin J, Aster RH. Variable expression of w4 and w6 on platelets: possible relevance to platelet transfusion therapy of alloimmunized thrombocytopenic patients. Transplant Proc. 1977;9:1829–31.PubMed
10.
Schiffer CA, O’Connell B, Lee EJ. Platelet transfusion therapy for alloimmunized patients: selective mismatching for HLA B12, an antigen with variable expression on platelets. Blood. 1989;74:1172–6.PubMed
11.
Freireich EJ, Judson G, Levin RH. Separation and collection of leukocytes. Cancer Res. 1965;25:1516–20.PubMed
12.
Nusbacher J, Scher ML, MacPherson JL. Plateletpheresis using the haemonetics model 30 cell separator. Vox Sang. 1977;33:9–15.PubMedCrossRef
13.
Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. The Trial to Reduce Alloimmunization to Platelets Study Group. N Engl J Med 1997;337:1861–9.
14.
Daly PA, Schiffer CA, Aisner J, Wiernik PH. A comparison of platelets prepared by the Haemonetics Model 30 and multiunit bag plateletpheresis. Transfusion. 1979;19:778–81.PubMedCrossRef
15.
O’Connell BA, Lee EJ, Rothko K, Hussein MA, Schiffer CA. Selection of histocompatible apheresis platelet donors by cross-matching random donor platelet concentrates. Blood. 1992;79:527–31.PubMed
16.
Freedman J, Hooi C, Garvey MB. Prospective platelet crossmatching for selection of compatible random donors. Br J Haematol. 1984;56:9–18.PubMedCrossRef
17.
Hogge DE, Dutcher JP, Aisner J, Schiffer CA. Lymphocytotoxic antibody is a predictor of response to random donor platelet transfusion. Am J Hematol. 1983;14:363–9.PubMedCrossRef
18.
Heddle NM, Klama L, Singer J, Richards C, Fedak P, Walker J, et al. The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med. 1994;331:625–8.PubMedCrossRef
19.
Gaydos LA, Freireich EJ, Mantel N. The quantitative relation between platelet count and hemorrhage in patients with acute leukemia. N Engl J Med. 1962;266:905–9.PubMedCrossRef
20.
Rebulla P, Finazzi G, Marangoni F, et al. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell’Adulto. N Engl J Med. 1997;337:1870–5.PubMedCrossRef

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jun 6, 2017 | Posted by in ONCOLOGY | Comments Off on Supportive Care for Patients with Leukemia: A Historical Perspective

Full access? Get Clinical Tree

Get Clinical Tree app for offline access